| David Shulan, MD | |
|
8 Southwoods Blvd, Albany, NY 12211-2554 | |
| (518) 434-1446 | |
| (518) 434-2360 |
| Full Name | David Shulan |
|---|---|
| Gender | Male |
| Speciality | Allergy & Immunology - Allergy |
| Location | 8 Southwoods Blvd, Albany, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326049123 | NPI | - | NPPES |
| 00898628 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | 161240 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David Shulan, MD 8 Southwoods Blvd, Albany, NY 12211-2554 Ph: (518) 434-1446 | David Shulan, MD 8 Southwoods Blvd, Albany, NY 12211-2554 Ph: (518) 434-1446 |
News Archive
Varian Medical Systems has received FDA 510(k) clearance for a new radiotherapy treatment planning tool designed to work with the company's market leading Eclipse™ treatment planning software to reduce the amount of time needed for planning advanced treatments.
Researchers from MD Anderson Cancer Center determined patients with osteoarthritis (OA) of the knee who are treated with traditional Chinese acupuncture (TCA) do not experience any more benefit than those receiving sham acupuncture (placebo).
A recent study published in the journal Nature Medicine, led by researchers Todd Allen, PhD, a professor of Medicine at Harvard Medical School and group leader at the Ragon Institute of MGH, MIT and Harvard, and Jim Riley, PhD, a professor of Microbiology in the Perelman School of Medicine at the University of Pennsylvania, describes a new Dual CAR T cell immunotherapy that can help fight HIV infection.
Teva Pharmaceutical Industries Ltd. announced today the termination of its collaboration with CureTech Ltd.
Researchers from China and the United Kingdom have collaborated to conduct a clinical trial looking at the efficacy of a combination of two anti-HIV drugs lopinavir and ritonavir to combat severe cases of COVID-19. Their study titled, "A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe COVID-19," was published in the latest issue of the New England Journal of Medicine (NEJM).
› Verified 5 days ago
Nancy Wade, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 8 Southwoods Blvd, Albany, NY 12211 Phone: 518-434-1446 Fax: 518-434-2360 | |
Michael Katlan, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 8 Southwoods Blvd, Albany, NY 12211 Phone: 518-434-1446 Fax: 518-434-2360 | |
Janet Claassen, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 8 Southwoods Blvd, Albany, NY 12211 Phone: 518-434-1446 Fax: 518-434-2360 | |
Dr. Muhammad Asghar Pasha, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 215 Washington Avenue Ext, Albany, NY 12205 Phone: 518-452-2510 Fax: 518-452-2683 | |
Dr. Jocelyn Celestin, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 215 Washington Avenue Ext, Albany, NY 12205 Phone: 518-452-2510 Fax: 518-452-2683 | |
James Michael Demasi, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 4 Executive Park Dr, Albany, NY 12203 Phone: 518-437-1890 Fax: 518-489-3295 |